General Information of the Compound
Compound ID
CP0457788
Compound Name
1-[2-(4-methylphenyl)ethyl]pyrrolidine
    Show/Hide
Synonyms
1-(2-p-tolyl-ethyl)-pyrrolidine
CHEMBL257912
SCHEMBL13164030
    Show/Hide
Structure
Formula
C13H19N
Molecular Weight
189.302
Canonical SMILES
Cc1ccc(CCN2CCCC2)cc1
    Show/Hide
InChI
InChI=1S/C13H19N/c1-12-4-6-13(7-5-12)8-11-14-9-2-3-10-14/h4-7H,2-3,8-11H2,1H3
    Show/Hide
InChIKey
RLADTPQRCGVXDS-UHFFFAOYSA-N
Physicochemical Property
logP
2.63332
Rotatable Bonds
3
Heavy Atom Count
14
Polar Areas
3.24
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Complexity
14

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44456128
ChEMBL ID
CHEMBL257912
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 81 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-(2-p-tolyl-ethyl)-pyrrolidine )
Drug Name 1-(2-p-tolyl-ethyl)-pyrrolidine
Target(s)
Histamine H3 receptor (H3R)
Inhibitor